A detailed history of Aqr Capital Management LLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 107,373 shares of ANIK stock, worth $2.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107,373
Previous 99,301 8.13%
Holding current value
$2.63 Million
Previous $2.52 Million 7.81%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$24.57 - $28.47 $198,329 - $229,809
8,072 Added 8.13%
107,373 $2.72 Million
Q1 2024

May 15, 2024

BUY
$21.95 - $26.42 $113,042 - $136,063
5,150 Added 5.47%
99,301 $2.52 Million
Q4 2023

Feb 14, 2024

BUY
$18.47 - $23.3 $380,426 - $479,910
20,597 Added 28.0%
94,151 $2.13 Million
Q3 2023

Nov 14, 2023

BUY
$16.98 - $26.1 $704,313 - $1.08 Million
41,479 Added 129.32%
73,554 $1.37 Million
Q2 2023

Aug 14, 2023

BUY
$25.16 - $28.86 $6,315 - $7,243
251 Added 0.79%
32,075 $833,000
Q1 2023

May 15, 2023

SELL
$25.91 - $32.1 $440 - $545
-17 Reduced 0.05%
31,824 $913,000
Q4 2022

Feb 14, 2023

BUY
$23.85 - $31.91 $177,706 - $237,761
7,451 Added 30.55%
31,841 $942,000
Q3 2022

Nov 14, 2022

BUY
$21.74 - $24.68 $210,551 - $239,025
9,685 Added 65.86%
24,390 $580,000
Q2 2022

Aug 15, 2022

BUY
$20.4 - $25.53 $299,982 - $375,418
14,705 New
14,705 $328,000
Q4 2020

Feb 16, 2021

SELL
$32.59 - $45.26 $1.75 Million - $2.43 Million
-53,796 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$32.56 - $38.57 $2.08 Million - $2.47 Million
-63,996 Reduced 54.33%
53,796 $1.9 Million
Q2 2020

Aug 17, 2020

SELL
$27.83 - $37.73 $101,718 - $137,903
-3,655 Reduced 3.01%
117,792 $4.44 Million
Q1 2020

May 15, 2020

BUY
$22.38 - $54.06 $702,015 - $1.7 Million
31,368 Added 34.82%
121,447 $3.51 Million
Q4 2019

Feb 14, 2020

BUY
$51.85 - $73.36 $2.83 Million - $4.01 Million
54,668 Added 154.38%
90,079 $4.67 Million
Q3 2019

Nov 14, 2019

BUY
$40.05 - $57.47 $1.18 Million - $1.69 Million
29,398 Added 488.91%
35,411 $1.94 Million
Q2 2019

Aug 14, 2019

SELL
$30.3 - $41.14 $299,030 - $406,010
-9,869 Reduced 62.14%
6,013 $244,000
Q1 2019

May 14, 2019

BUY
$29.37 - $40.49 $22,761 - $31,379
775 Added 5.13%
15,882 $480,000
Q4 2018

Feb 14, 2019

BUY
$30.16 - $43.0 $5,338 - $7,611
177 Added 1.19%
15,107 $508,000
Q3 2018

Nov 15, 2018

SELL
$32.83 - $42.51 $465,956 - $603,344
-14,193 Reduced 48.73%
14,930 $629,000
Q2 2018

Aug 14, 2018

SELL
$28.77 - $48.27 $410,058 - $687,992
-14,253 Reduced 32.86%
29,123 $932,000
Q1 2018

May 15, 2018

BUY
$49.22 - $68.43 $27,169 - $37,773
552 Added 1.29%
43,376 $2.16 Million
Q4 2017

Feb 14, 2018

SELL
$52.14 - $59.94 $232,283 - $267,032
-4,455 Reduced 9.42%
42,824 $2.31 Million
Q3 2017

Nov 14, 2017

BUY
$51.16 - $58.21 $2.42 Million - $2.75 Million
47,279
47,279 $2.74 Million

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $358M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.